Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Glioma
IDH-mutant astrocytoma and oligodendroglioma, IDH inhibitors, and BRAF- and H3-altered tumours.
SITC Annual Meeting 2026
4–8 Nov 2026, Phoenix · Journal for ImmunoTherapy of Cancer 14 (Suppl 2 and 3), open access
1,109 regular and 19 late-breaking abstracts are in Crossref as open-access JITC supplement records (CC BY-NC); the supplement may still be filling in.
Indexed in Crossref
7 abstracts matching glioma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 11:27 UTC. This is a keyword search, not the complete abstract book.
- 1028Pan-glioma immunogenomic atlas reveals naturally inflamed ultra-hypermutated immune subtypePratayanch Sav, Bettina Lee
- 1102Acid ceramidase inhibition induces ER stress, apoptosis, and an immune-visible phenotype in IDH-mutant oligodendrogliomaHelena Muley Vilamu, Tyrone Dowdy, Viney Kumar, Faris Zaibaq et al.
- 334Phase 1 trial of GC101, an IL2free autologous tumor-infiltrating lymphocyte (TIL) therapy, in recurrent high-grade glioma: safety and preliminary efficacyYanming Chen, Wenjia Zhuang, Ying Cheng, Huajun Jin et al.
- 752Phagocytosis-dependent chromatin remodeling governs macrophage activation states in pediatric and adult gliomaSenthilnath Lakshmanachetty, Andrew Donson, Sai Pradeep Chandra Bompada, Vincent Chen et al.
- 936Immune-engineering spherical nucleic acids for neuro-lymphatic targeting of gliomaAkanksha S Mahajan, Xinhe Shen, Davin Hickman Chow, Naiyan Wu et al.
- 1111NIR light mediated mechanical destruction of glioma cells to trigger tumor antigen release and potentiate immunogenic cell deathPrapannajeet Biswal, Arjun B Vasan, Aria Sabbagh, Sai Kumar Samala et al.
- 323Adaptive anti-CAR immunity compromises the durability of GD2-CAR T cell therapy in diffuse midline gliomaKevin M Reynolds, Camille F Petrakian, Yiyun Chen, Elena Sotillo et al.